On this episode, Dr. K welcomes Dr. Amar Naik of Midwest Digestive Health and Nutrition, a new GI Practice in the Chicago suburbs where he is the founding partner and Director of the IBD Program. He shared his commitment to advancing IBD care in a private practice setting, noting the need for a potential future board certification specifically for IBD. Despite transitioning from academia to private practice, he emphasized his ongoing dedication to research and data-driven insights. Dr. Naik highlighted the role of private practices in conducting impactful, community-based clinical trials, making advanced therapies accessible to more diverse patient populations. He sees these trials as beneficial for collecting real-world data on broader IBD demographics, including different racial and ethnic groups.
Dr. Naik also expressed appreciation for the support networks and resources offered by professional societies like the AGA, especially as a way to connect younger practitioners with mentors in both academic and community-based settings. Speaking on his practice’s recent partnership with SonarMD, he underscored its role in enhancing patient monitoring between visits and improving care continuity. SonarMD’s model, he explained, allows his team to bridge the gap between knowing patients need follow-up and actually delivering it, ensuring that patients feel well-supported in their care journey.
Takeaways
- Expanding Access to Community-Based Trials: Dr. Naik emphasized the importance of community-based clinical trials for IBD, which allow more diverse and representative patient groups to access cutting-edge therapies, as well as provide critical data on broader demographics and real-world outcomes.
- Support from Professional Societies: Dr. Naik praised organizations like the AGA for providing valuable resources and networking opportunities, especially to connect younger practitioners with experienced mentors across both academic and community settings.
- Enhanced Patient Monitoring with SonarMD: Dr. Naik sees SonarMD as a vital tool for bridging care gaps between visits for patients with chronic GI conditions, like IBD, helping to ensure consistent patient monitoring and demonstrating to patients the practice’s dedication to proactive care.
This article was originally published on the SonarMD website and is republished here with permission.
About the Show
An inside look at value-based care in GI
Listen in as Dr. K brings patients, providers and payers together to reimagine GI care in America. He and his guests will discuss emerging trends, research, care and payment models, technologies, regulatory pressures, policies and more. It’s time for a gut check on how GI can help meet the quadruple aim in healthcare: an improved patient experience, better health of the overall population, lower costs and happier providers.
Show rebroadcasts at 8:00am, 4:00pm and 12:00 am ET every weekday.
About Dr. K
Dr. Lawrence Kosinski (@lrkosinski) is the Founder and Chief Medical Officer of SonarMD – a care coordination and drug optimization solution for gut health. After spending 30+ years of his career as a leading clinician and researcher in gastroenterology, Dr. K is now 100% dedicated to bringing patients, providers and payers together to advance value-based care. Dr. K is routinely tapped to present at leading GI and payer conferences, including DDW, GI Outlook, AHIP and others. He has published numerous research projects and previously served on the governing board of the American Gastroenterological Association.
Read Dr. K’s full bio and learn more about the SonarMD team.